Funded Local Who is raising money in your own backyard?

VANCOUVER, BC, April 6, 2009 – Ondine Biopharma Corporation (the “Company” or “Ondine”, TSX: OBP; AIM: OBP) a medical technology company developing photodisinfection based products, today announced that it has entered into a loan agreement with Carolyn Cross, Chairman, CEO and a shareholder of the Company, pursuant to which Ms. Cross has advanced the Company C$400,000 (the “Loan”), demonstrating continued support of the Company. Ms.

Vancouver, Canada – February 23, 2009 - Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) (the “Company”) a medical technology company developing photodisinfection based products, today announced it has closed the second tranche of its previously announced non-brokered private placement by issuing 1,650,168 common shares at a price of $0.06 per share for aggregate gross proceeds of C$99,010 to qualified investors pursuant to applicable exemptions.

Vancouver, Canada – February 17, 2009 - Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) (the “Company”) a medical technology company developing photodisinfection based products, today announced it has closed the first tranche of its previously announced non-brokered private placement by issuing 6,970,000 common shares at a price of $0.06 per share for aggregate gross proceeds of C$418,200 to qualified investors pursuant to applicable exemptions.

VANCOUVER, BC -- Forbes Medi-Tech Inc. (TSX:FMI; NASDAQ:FMTI) ("Forbes" or "Company") announced today that its subsidiary known as Forbes Medi-Tech Operations Inc. ("FMTO") or "3887685 Canada Inc." is undertaking a transaction that, upon closing and subject to certain conditions, will provide Forbes with an opportunity to realize an anticipated minimum of approximately $800,000 in additional funding from its Non-Dilutive Funding Transaction, which was originally announced on March 20, 2008, with the subsequent closing announced on May 12, 2008.

VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that it has completed the first tranche of a non-brokered private placement in the amount of $582,750 through the issuance of 2,913,750 Units at a subscription price of $0.20 per Unit. Each Unit will consist of one common share in the capital of the Company (a “Common Share”) and one-half of a Common Share purchase warrant (a “Warrant”).

OneMove Technologies Inc. ("OneMove" or the "Company") (TSX-V: OM), a provider of a leading web-based real estate transaction platform, announced today that its previously announced non-brokered private placement was fully subscribed and closed on September 4, 2008.

September 2, 2008 - Burnaby, BC, Canada - International Water-Guard Industries Inc. (IWG) has closed a private placement of $500,000, President & Chief Executive Officer David C. Fox announced.

Victoria, B.C., August 11, 2008 - CardioComm Solutions, Inc. (TSX-V: EKG) ("CardioComm" or the "Company") today announced that it has closed its previously announced non-brokered private placement equity financing. Under the financing, the Company issued 3,500,000 units at a price of $0.10 per unit, with each unit comprising one common share of the Company and one common share purchase warrant exercisable for an additional share at a price of $0.20. The Company realized gross proceeds of $350,000 from the financing, which will be used for general working capital of the Company.

Vancouver, July 30, 2008 - IP Applications Corp. (TSX-V: IPX) (the “Company”) is pleased to announce that further to the Company’s news release of June 20, 2008, it has received final acceptance from the TSX Venture Exchange and formally closed its non-brokered private placement of 3,875,000 Units, at a price of $0.20 per Unit, raising gross proceeds of $775,000. Each Unit consisted of one common share and one-half common share purchase warrant.

See NeoVasc Company listing for more details.